Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1)

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1)

 EDITORIAL 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):1-2

Editor’s page

Bisi G.


 EDITORIAL MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):3-5

Theranostic role of MIBG in neuroblastoma

Aktolun C., Castellani M. R.


 REVIEWS MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):6-20

Functional-metabolic imaging of neuroblastoma

Sharp S. E., Parisi M. T., Gelfand M. J., Yanik G. A., Shulkin B. L.


 REVIEWS MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):21-8

Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors

Liu B., Zhuang H., Servaes S.


 REVIEWS MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):29-39

PET/CT imaging in neuroblastoma

Piccardo A., Lopci E., Conte M., Foppiani L., Garaventa A., Cabria M., Villavecchia G., Fanti S., Cistaro A.


 REVIEWS MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):40-52

Contemporary approach to diagnosis and treatment of neuroblastoma

Charron M.


 REVIEWS MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):53-65

131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma

Dubois S. G., Matthay K. K.


 REVIEWS MIBG IN NEUROBLASTOMA 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):66-78

Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma

Gaze M. N., Gains J. E., Walker C., Bomanji J. B.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):79-91

Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET

Hobbs R. F., Jentzen W., Bockisch A., Sgouros G.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):92-100

First clinical experience with a dedicated PET for hanging breast molecular imaging

Koolen B. B., Aukema T. S., González Martínez A. J., Vogel W. V., Caballero Ontanaya L., Vrancken Peeters M.-J. T.F.D., Vroonland C. J. J., Rutgers E. J. TH., Benlloch Baviera J. M., Valdés Olmos R. A.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):101-8

Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions

Yoshimura M., Tsutsui H., Ikeda N., Koizumi K.


inizio pagina